A case of esophageal small cell carcinoma with multiple liver metastases responding to chemotherapy with irinotecan plus cisplatin

Journal of Experimental and Clinical Cancer Research

Volumn 24, Issue 4, 2005, Pages 647-650

  Endo, Kazuya ^a   Kohnoe, S ^b   Toh, Y ^b   Haraguchi, M ^b   Nishiyama, K ^b   Okamura, T ^b   Baba, H ^c   Maehara, Y ^c  

^a FUKUOKA DENTAL COLLEGE   (Japan)

^b NATIONAL KYUSHU CANCER CENTER   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Esophageal small cell carcinoma; Irinotecan plus cisplatin

Indexed keywords

CISPLATIN; FLUOROURACIL; IRINOTECAN;

AGED; ANOREXIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RELAPSE; CASE REPORT; CAUSE OF DEATH; DRUG RESPONSE; ENDOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; ESOPHAGUS SMALL CELL CARCINOMA; FATIGUE; HUMAN; HUMAN TISSUE; LIVER FAILURE; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; NEUTROPENIA; PRIORITY JOURNAL; PROGNOSIS; RADIOLOGY; SURVIVAL TIME; TUMOR VOLUME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CARCINOMA, SMALL CELL; CISPLATIN; ESOPHAGEAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; MALE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 31344442491     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Beyer K.L., Marshall J.B., Diaz-Arias A.A., Loy T.S.: Primary small-cell carcinoma of the esophagus. Report of 11 cases and review of the literature. J. Clin. Gastroenterol. 13: 135-141, 1991.
2. Casas F., Ferrer F., Farrus B., Casais J., Biete A.: Primary small cell carcinoma of the esophagus: A review of the literature with emphasis on therapy and prognosis. Cancer 80 : 1366-1372, 1997.
3. Nichols G.L., Kelsen D.P.: Small cell carcinoma of the esophagus. The Memorial Hospital experience 1970 to 1987. Cancer 64: 1531-1533, 1989.
4. Craig S.R., Carey F.A., Walker W.S., Cameron E.W.: Primary small cell carcinoma of the esophagus. Thorac. Cardiovasc. Surg. 109: 284-288, 1995.
5. Bennouna J., Bardet E., Deguiral P., Douillard J.Y.: Small cell carcinoma of the esophagus: Analysis of 10 cases and review of the published data. Am. J. Clin. Oncol. 23: 455-459, 2000.
6. Kanazawa F., Akiyama Y., Saijo N., Nishio K.: In vitro effects of combinations of cis-amminedichloro(2-methylpyridine) platinum(II)(ZD0473) with other novel anticancer drugs on the growth of SBC-3, a human small cell lung cancer cell line. Lung Cancer 40: 325-332, 2003.
7. Takigawa N., Fujiwara K., Ueoka H. et al.: Fractionated administration of irinotecan and cisplatin for treatment of extensive-disease small-cell lung cancer: a phase II study. Anticancer Res. 23: 557-560, 2003.
8. Schneider J., Philipp M., Velcovsky H.G., Morr H., Katz N.: Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE) in therapy control of patients with small cell lung cancer. Clin. Lab. 49: 35-42, 2003.
9. Jereczek-Fossa B., Airoldi M., Gribaudo S., Ruo Redda M.G., Valente G., Orecchia F.: Small cell carcinoma of the Esophagus. Neoplasm 46: 7-11, 1999.
10. Mckeown F.: Oat-cell carcinoma of the esophagus. J. Pathol. Bacteriol. 64: 889-891, 1952.
11. Fujiwara Y., Nakagawa K., Tanaka T., Utsunomiya J., Nishigami Y., Uematsu K.: Small cell carcinoma of the esophagus combined with superficial esophageal cancer. Hepatogastroenterol. 43: 1360-1369, 1996.
12. Ageiaki S., Syrigos K., Christophylakis C. et al.: A multicenter phase II study of the combination of irinotecan and gemcitabine in previously treated patients with small-cell lung cancer. Oncology 66: 192-196, 2004.
13. Yoshikawa M., Ikegami Y., Hayasaka S. et al.: Novel camptothecin analogues that circumvent ABCG-2 associated drug resistance in human tumor cells. Int. J. Cancer 110: 921-927, 2004.